A new law in Washington requiring pharmaceutical sales representatives to obtain a special license to sell pharmaceutical products in the District will not affect representatives attending medical meetings or conventions in D.C. The SafeRX law, which went into effect April 1, created concern for medical meeting planners who thought that the legislation might have an impact on their meetings. Initially, the law was not clear on how it would affect pharmaceutical sales representatives, also ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to D.C. Pharma Marketing Law Exempts Meetings, you'll get exclusive access to a large archive of premium content.

Already registered? here.